Large gap with delayed quotes
|
Last quote
10/17/2026
-
02:00:00
|
Bid
10/16/2026 -
21:59:58
|
Bid Volume |
Ask
10/16/2026 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
0.5866
-0.0199
(
-3.28% )
|
0.5789
|
100 |
0.5852
|
500 |
Analysis date: 13.10.2026
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 06.10.2026.
Quality
Weak
Weak
Two stars since 13.10.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 23.01.2026 at a price of 3.47.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 29.09.2026.
4wk Rel Perf
-33.59%
-33.59%
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 33.59% behind the SP500.
Risk
High
High
High, no change over 1 year.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 2.01%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.63%.
Mkt Cap in $bn
0.02
0.02
With a market capitalization <$2bn, EHEALTH is considered a small-cap stock.
G/PE Ratio
-9.78
-9.78
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
0.69
0.69
The estimated PE is for the year 2027.
LT Growth
-6.71%
-6.71%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
131
131
For 1% of index variation, the stock varies on average by 1.31%.
Correlation
0.23
0.23
Stock movements are strongly independent of index variations.
Value at Risk
0.15
0.15
The value at risk is estimated at USD 0.15. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
11.07.2008
11.07.2008